The health insurance giant is the latest to remove references to diversity, equity and inclusion policies amid mounting ...
I-Mab (NASDAQ: IMAB) is a US-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations in Rockville, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback